rs2248462

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000718213.1(HCP5):​n.96-11643G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.194 in 151,792 control chromosomes in the GnomAD database, including 3,184 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.19 ( 3184 hom., cov: 32)

Consequence

HCP5
ENST00000718213.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.133

Publications

65 publications found
Variant links:
Genes affected
HCP5 (HGNC:21659): (HLA complex P5)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000718213.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.254 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000718213.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HCP5
ENST00000718213.1
n.96-11643G>A
intron
N/A
HCP5
ENST00000718214.1
n.96-11643G>A
intron
N/A
HCP5
ENST00000666495.2
n.*83G>A
downstream_gene
N/A

Frequencies

GnomAD3 genomes
AF:
0.194
AC:
29427
AN:
151670
Hom.:
3179
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.138
Gnomad AMI
AF:
0.318
Gnomad AMR
AF:
0.260
Gnomad ASJ
AF:
0.185
Gnomad EAS
AF:
0.169
Gnomad SAS
AF:
0.207
Gnomad FIN
AF:
0.164
Gnomad MID
AF:
0.156
Gnomad NFE
AF:
0.218
Gnomad OTH
AF:
0.198
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.194
AC:
29452
AN:
151792
Hom.:
3184
Cov.:
32
AF XY:
0.194
AC XY:
14419
AN XY:
74212
show subpopulations
African (AFR)
AF:
0.138
AC:
5700
AN:
41320
American (AMR)
AF:
0.261
AC:
3962
AN:
15206
Ashkenazi Jewish (ASJ)
AF:
0.185
AC:
644
AN:
3472
East Asian (EAS)
AF:
0.170
AC:
873
AN:
5148
South Asian (SAS)
AF:
0.207
AC:
995
AN:
4810
European-Finnish (FIN)
AF:
0.164
AC:
1735
AN:
10578
Middle Eastern (MID)
AF:
0.158
AC:
46
AN:
292
European-Non Finnish (NFE)
AF:
0.218
AC:
14787
AN:
67952
Other (OTH)
AF:
0.200
AC:
422
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1186
2371
3557
4742
5928
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
320
640
960
1280
1600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.209
Hom.:
14100
Bravo
AF:
0.201
Asia WGS
AF:
0.172
AC:
600
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.0
DANN
Benign
0.28
PhyloP100
-0.13

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2248462;
hg19: chr6-31446796;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.